Literature DB >> 30541760

Propensity-matched analysis of minimally invasive approach versus sternotomy for mitral valve surgery.

Stuart W Grant1, Graeme L Hickey2, Paul Modi3, Steven Hunter4, Enoch Akowuah5, Joseph Zacharias6.   

Abstract

OBJECTIVE: The objective of this multicentre study was to compare short-term and midterm outcomes between sternotomy and minimally invasive approaches for mitral valve surgery.
METHODS: Data for all mitral valve procedures with or without concomitant tricuspid atrial fibrillation surgery were analysed from three UK hospitals between January 2008 and December 2016. To account for selection bias between minimally invasive approach and sternotomy, one-to-one propensity score calliper matching without replacement was performed. The main outcome measure was midterm reintervention free survival that was summarised by the Kaplan-Meier estimator and compared between treatment arms using the stratified log-rank test.
RESULTS: A total of 2404 procedures (1757 sternotomy and 647 minimally invasive) were performed during the study period. Propensity score matching resulted in 639 matched pairs with improved balance postmatching in all 31 covariates (absolute standardised mean differences <10%). Despite longer procedural times patients who underwent minimally invasive surgery had a lower need for transfusion (20.5%vs14.4%, p=0.005) and reduced median postoperative length of stay (7 vs 6 days, p<0.001). There were no statistically significant differences in the rates of in-hospital mortality or postoperative stroke. Reintervention-free survival at 8 years was estimated as 86.1% in the minimally invasive group and 84.1% in the sternotomy group (p=0.40).
CONCLUSIONS: Minimally invasive surgery is associated with excellent short-term outcomes and comparable midterm outcomes for patients undergoing mitral valve surgery. A minimally invasive approach should be considered for all patients who require mitral valve intervention and should be the standard against which transcatheter mitral techniques are compared. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  mitral regurgitation; mitral stenosis; quality and outcomes of care; valve disease surgery

Year:  2018        PMID: 30541760     DOI: 10.1136/heartjnl-2018-314049

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  10 in total

1.  Trends in redo mitral procedure for treating mitral bioprostheses failure: a single center's experience.

Authors:  Jian Liu; Peijian Wei; Yanjun Liu; Jiexu Ma; Hongxiang Wu; Tong Tan; Zhao Chen; Jimei Chen; Huanlei Huang; Huiming Guo
Journal:  Ann Transl Med       Date:  2021-08

2.  Machine learning models to predict red blood cell transfusion in patients undergoing mitral valve surgery.

Authors:  Shun Liu; Rong Zhou; Xing-Qiu Xia; He Ren; Le-Ye Wang; Rui-Rui Sang; Mi Jiang; Chun-Chen Yang; Huan Liu; Lai Wei; Rui-Ming Rong
Journal:  Ann Transl Med       Date:  2021-04

3.  The Treatment of Mitral Valve Disease-The Only Thing Constant is Change.

Authors:  Joseph Zacharias; Ernesto Greco
Journal:  Biomedicines       Date:  2021-01-28

4.  Minimally invasive versus conventional sternotomy for Mitral valve repair: protocol for a multicentre randomised controlled trial (UK Mini Mitral).

Authors:  Rebecca H Maier; Adetayo S Kasim; Joseph Zacharias; Luke Vale; Richard Graham; Antony Walker; Grzegorz Laskawski; Ranjit Deshpande; Andrew Goodwin; Simon Kendall; Gavin J Murphy; Vipin Zamvar; Renzo Pessotto; Clinton Lloyd; Malcolm Dalrymple-Hay; Roberto Casula; Hunaid A Vohra; Franco Ciulli; Massimo Caputo; Serban Stoica; Max Baghai; Gunaratnam Niranjan; Prakash P Punjabi; Olaf Wendler; Leanne Marsay; Cristina Fernandez-Garcia; Paul Modi; Bilal H Kirmani; Mark D Pullan; Andrew D Muir; Dimitrios Pousios; Helen C Hancock; Enoch Akowuah
Journal:  BMJ Open       Date:  2021-04-14       Impact factor: 2.692

5.  A Propensity Score Analysis of Early and Long-Term Outcomes of Retrograde Arterial Perfusion for Endoscopic and Minimally Invasive Heart Valve Surgery in Both Young and Elderly Patients.

Authors:  Hind Elhassan; Abdelrahman Abdelbar; Rebecca Taylor; Grzegorz Laskawski; Palanikumar Saravanan; Andrew Knowles; Joseph Zacharias
Journal:  J Cardiovasc Dev Dis       Date:  2022-01-28

6.  Early Outcomes of Endoscopic Papillary Muscle Relocation for Secondary Mitral Regurgitation Type IIIb in Patients With Severe Left Ventricular Dysfunction.

Authors:  Jonas Pausch; Oliver D Bhadra; Tatiana M Sequeira Gross; Xiaoqin Hua; Lenard Conradi; Hermann Reichenspurner; Evaldas Girdauskas
Journal:  Innovations (Phila)       Date:  2022-08-19

7.  Long-term results after mitral valve surgery using minimally invasive versus sternotomy approach: a propensity matched comparison of a large single-center series.

Authors:  Ayse Cetinkaya; Anna Geier; Karin Bramlage; Stefan Hein; Peter Bramlage; Markus Schönburg; Yeong-Hoon Choi; Manfred Richter
Journal:  BMC Cardiovasc Disord       Date:  2021-06-26       Impact factor: 2.298

8.  Bretschneider (Custodiol®) and St. Thomas 2 Cardioplegia Solution in Mitral Valve Repair via Anterolateral Right Thoracotomy: A Propensity-Modelled Comparison.

Authors:  Constantin Mork; Luca Koechlin; Thibault Schaeffer; Lena Schoemig; Urs Zenklusen; Brigitta Gahl; Oliver Reuthebuch; Friedrich S Eckstein; Martin T R Grapow
Journal:  Mediators Inflamm       Date:  2019-12-04       Impact factor: 4.711

9.  Minimally invasive mitral valve surgery: a systematic safety analysis.

Authors:  Kinsing Ko; Thom L de Kroon; Nabil Saouti; Bart P van Putte; Marco C Post; Johannes C Kelder; Karen F Schut
Journal:  Open Heart       Date:  2020-10

10.  Long-term outcomes of a totally thoracoscopic approach for reoperative mitral valve replacement: a propensity score matched analysis.

Authors:  Peijian Wei; Jian Liu; Jiexu Ma; Yuyuan Zhang; Zhao Chen; Yanjun Liu; Tong Tan; Hongxiang Wu; Jimei Chen; Jian Zhuang; Huiming Guo
Journal:  Ann Transl Med       Date:  2021-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.